YOLFTbeta
HEM Pharma Inc.

HEM Pharma Inc.

376270 · KQ · Healthcare / Biotechnology

21,500.00KRW-200.00 (-0.92%)

Price History

Full chart

Market Stats

Previous Close21,700.00
Open22,000.00
Day Range20,900.00 – 22,300.00
52-Week Range25,800.00 – 97,500.00
Volume6.74K
Market Cap249.37B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
50-Day Avg38,051.00
200-Day Avg54,732.50

About

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Yosep Ji
  • Headquarters102, Business incubator center, Pohang, South Korea, 37554, Korea
  • Websitehttps://www.hempharma.bio

Leadership

  • Mr. Yosep JiChief Executive Officer
  • DeokGeun LeeCFO & VP
  • Mr. Wilhelm Heinrich HolzapfelChief Technology Officer · b. 1942

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue3.67B5.34B15.07B12.98B
Growth (%)-+45.70%+181.95%-13.86%
Cost of Revenue3.04B4.54B13.45B12.35B
Gross Profit623.50M800.51M1.62B631.54M
Gross Margin17.00%14.98%10.76%4.87%
Operating Expense13.87B12.56B9.30B16.21B
Operating Income-13.24B-11.76B-7.68B-15.58B
Operating Margin-361.04%-220.08%-50.98%-120.06%
EBITDA-10.56B-9.13B-4.93B-20.48B
EBITDA Margin-287.90%-170.90%-32.70%-157.76%
Net Income-13.01B-11.67B-7.65B-23.84B
Net Income Margin-354.67%-218.31%-50.75%-183.69%
R&D6.91B4.11B3.21B3.84B
R&D as % of Total Revenue188.34%76.98%21.32%29.58%
Interest Expense2.73M82.29M261.78M649.13M
Interest Expense % of Total Revenue0.07%1.54%1.74%5.00%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets34.83B27.82B36.86B51.83B
Total Liabilities14.60B10.45B10.74B46.62B
Total Equity20.23B17.38B26.12B4.99B
Cash2.16B8.15B6.27B13.78B
Net Debt9.63B-197.99M3.40B

Cash Flow

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-11.13B-5.27B-7.68B-8.34B
Capital Expenditure10.27B4.54B4.80B9.98B
Free Cash Flow-21.40B-9.81B-12.48B-18.33B
FCF to OCF192.27%186.17%162.48%219.65%

Earnings

Report DateDec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------
EPS Actual-294.58-335.28-469.69-502.05-2055.87-580.38209.24
Surprise-------
Timing-------

Key Statistics & Ratios

Market Cap249.37B
Enterprise Value255.19B
Trailing P/E0.00
Forward P/E0.00
Price / Sales15.45
Price / Book16.96
Revenue (TTM)16.14B
Gross Profit (TTM)2.05B
EBITDA-14.27B
Profit Margin-129.30%
Operating Margin-62.50%
Return on Equity-108.52%
Return on Assets-22.86%
Shares Outstanding7.18M
Shares Float4.30M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%